CathLab.com was created by healthcare professionals, for healthcare professionals.

Welcome

CathLab.com recognizes that today’s cardiac and vascular professionals are working in a field that is continually evolving in terms of diagnostic, interventional, therapeutic procedures and patient care. New products and technologies are introduced and adopted every day. As a result, there is a need for a site dedicated solely to the non-physician professional, which provides in-depth coverage on current topics. Our site is designed for cardiac and vascular nurses, technologists, educators, managers, and directors, sharing the latest product insights, news, and education on one website.

News

Embolic Protection During TAVR Reduces Volume of Cerebral Lesions, but Clinical Benefit Not Evident: Meta-analysis

May 26, 2017

“The use of embolic protection devices when performing transcatheter aortic valve replacement may be associated with a smaller volume of silent ischemic lesions, according to results of a new meta-analysis.”

DAWN Trial May Lay Groundwork for Extending Treatment Window for Acute Stroke Therapy

May 26, 2017

“Thrombectomy with a stent retriever improves functional outcomes in patients who wake up or present late with an acute ischemic stroke, at least when there is an initial mismatch consisting of substantial clinical deficits but a small infarct size, the randomized DAWN trial shows.”

Lotus TAVR System Shows Superior Efficacy to CoreValve in Global REPRISE III Trial

May 25, 2017

” Positive results from the REPRISE III clinical trial, presented at the annual EuroPCR Scientific Program, in Paris, demonstrated that the Boston Scientific Lotus Valve System, a transcatheter aortic valve implantation (TAVI) system, showed superiority over the Medtronic CoreValve TAVR System platform for the primary effectiveness endpoint and non-inferiority for the primary safety endpoint.”

Cardiovascular Disease Is a Major Worldwide Threat to Public Health, Global Analysis Finds

May 25, 2017

“Cardiovascular disease’s burden is growing in middle-income countries, and previous improvements in cardiovascular health have plateaued in the industrialized world and may even be regressing in some areas, according to a new analysis of 2015 data.”